118 employees
Slayback Pharma believe every pharmaceutical product exhibits its own unique personality.
2011
$60M
from 2 investors over 2 rounds
Slayback Pharma raised $50M on January 6, 2020
Investors: Everstone Group
Slayback Pharma raised $60M on January 5, 2017
Investors: KKR & Co. Inc.